Sepesi Boris
Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Thorac Surg Clin. 2017 May;27(2):159-163. doi: 10.1016/j.thorsurg.2017.01.009. Epub 2017 Mar 2.
Surgical treatment of locally advanced or recurrent breast cancer involving the chest wall continues to play a role in the therapeutic armamentarium as part of the multidisciplinary treatment regimen. Significant progress has been made in chest wall resections and reconstructions, thanks to the availability of novel materials and tissue transfer methods. The understanding of cancer biology and behavior, and novel drugs further improved the field. Patient selection and superb knowledge of the most recent and effective treatment options are necessary to maximize the survival benefit and quality of life for patients affected with breast cancer involving the chest wall.
作为多学科治疗方案的一部分，针对累及胸壁的局部晚期或复发性乳腺癌的手术治疗在治疗手段中仍发挥着作用。由于新型材料和组织移植方法的出现，胸壁切除和重建已取得显著进展。对癌症生物学和行为的认识以及新型药物进一步推动了该领域的发展。为了使累及胸壁的乳腺癌患者的生存获益和生活质量最大化，必须进行患者选择并充分了解最新、最有效的治疗方案。
